Case Study: Oncology Company Achieves ~80% Acceleration in Gene Target ID/ Validation

As the world is moving at breakneck speed toward larger models to improve accuracy, we take a step back from the rat race to take a more efficient and realistic look at the technology and explore how it can be improved in a more optimized and well-rounded manner. Join the exciting conversation between ML/NLP expert Dr. Ashutosh Modi and our BioNLP Director, Shashank Jatav, to learn more.